Sign in or create an account to add this stock to your watchlist.
About DS Healthcare Group (OTCMKTS:DSKX)
DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. Its technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells. The Company products are primarily sold under its DS Laboratories brand. It also sells certain products under its Polaris Labs and Sigma Skin brands. It markets and sells these products through salons, spas, department stores, specialty retailers and distributors. The Company offers products under three product categories: Hair Care, Skin Care and Personal Care.
Industry, Sector and Symbol
Industry Toilet preparations
Sub-IndustryN/A
SectorConsumer Staples
SymbolOTCMKTS:DSKX
CUSIPN/A
Phone888-404-7770
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$12.95 million
Price / Sales0.10
Cash FlowN/A
Price / CashN/A
Book Value$0.05 per share
Price / Book0.82
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees131
Outstanding Shares30,190,000
DS Healthcare Group (OTCMKTS:DSKX) Frequently Asked Questions
What is DS Healthcare Group's stock symbol?
DS Healthcare Group trades on the OTCMKTS under the ticker symbol "DSKX."
Who are some of DS Healthcare Group's key competitors?
Some companies that are related to DS Healthcare Group include Colgate-Palmolive (CL), Estée Lauder Companies (EL), Coty (COTY), Pola Orbis (PORBF), Hypera Pharma (HYPMY), Edgewell Personal Care (EPC), Mandom (MDOMF), Inter Parfums (IPAR), Revlon (REV), Eyes Lips Face (ELF), Avon Products (AVP), United-Guardian (UG) and 2050 Motors (ETFM).
Who are DS Healthcare Group's key executives?
DS Healthcare Group's management team includes the folowing people:
- Myron Lewis, Chairman of the Board
- Robert Bellaflores, Chief Financial Officer, Vice President, Controller, Director
- Manuel Gonzalez, Chief Commercial Officer
- Justina Ng Lian Ping, Director
Has DS Healthcare Group been receiving favorable news coverage?
Media coverage about DSKX stock has been trending somewhat positive recently, Accern reports. Accern identifies negative and positive news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. DS Healthcare Group earned a coverage optimism score of 0.01 on Accern's scale. They also gave news headlines about the specialty retailer an impact score of 45.81 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.
How do I buy shares of DS Healthcare Group?
Shares of DSKX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is DS Healthcare Group's stock price today?
One share of DSKX stock can currently be purchased for approximately $0.0410.
How big of a company is DS Healthcare Group?
DS Healthcare Group has a market capitalization of $1.24 million and generates $12.95 million in revenue each year. DS Healthcare Group employs 131 workers across the globe.
How can I contact DS Healthcare Group?
DS Healthcare Group's mailing address is 1601 GREEN ROAD, DEERFIELD BEACH FL, 33064. The specialty retailer can be reached via phone at 888-404-7770 or via email at [email protected]
MarketBeat Community Rating for DS Healthcare Group (DSKX)
MarketBeat's community ratings are surveys of what our community members think about DS Healthcare Group and other stocks. Vote "Outperform" if you believe DSKX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DSKX will underperform the S&P 500 over the long term. You may vote once every thirty days.
DS Healthcare Group (OTCMKTS:DSKX) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
(Data available from 5/20/2016 forward)
DS Healthcare Group (OTCMKTS:DSKX) Earnings History and Estimates Chart
DS Healthcare Group (OTCMKTS DSKX) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 8/14/2017 | Q2 2017 | | ($0.10) | | $2.23 million | View | N/A |  |
| 5/15/2017 | Q1 2017 | | ($0.05) | | $2.09 million | View | N/A | |
| 3/31/2017 | Q4 2016 | | ($0.08) | | $3.10 million | View | N/A | |
| 11/9/2016 | Q3 2016 | | ($0.05) | | $2.68 million | View | N/A | |
| 10/7/2016 | Q4 2015 | | ($0.56) | | $1.68 million | View | N/A | |
| 11/17/2015 | Q3 2015 | | ($0.03) | $3.73 million | $3.64 million | View | N/A | |
| 5/20/2015 | Q1 2015 | | ($0.01) | | $2.80 million | View | N/A | |
| 4/15/2015 | Q4 2014 | | $0.02 | | $3.71 million | View | N/A | |
| 8/15/2014 | Q2 2014 | | ($0.04) | | $3.74 million | View | N/A | |
| 5/15/2014 | Q1 2014 | | ($0.05) | | $2.69 million | View | N/A | |
| 4/4/2014 | Q4 2013 | | ($0.07) | | $3.06 million | View | N/A | |
| 11/15/2013 | Q3 2013 | | ($0.08) | | $3.20 million | View | N/A | |
| 8/20/2013 | Q2 2013 | | ($0.06) | | $3.43 million | View | N/A | |
| 5/16/2013 | Q1 2013 | | ($0.04) | | $3.97 million | View | N/A | |
| 4/23/2013 | Q4 2012 | | ($0.25) | | | View | N/A | |
| 8/14/2012 | Q2 2012 | | ($0.03) | | | View | N/A | |
| 11/15/2011 | Q3 2011 | | ($0.04) | | | View | N/A | |
| 8/23/2011 | Q2 2011 | | ($0.01) | | | View | N/A | |
| 11/15/2010 | Q3 2010 | | $0.01 | | | View | N/A | |
| 8/16/2010 | Q2 2010 | | $0.03 | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
DS Healthcare Group (OTCMKTS:DSKX) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
DS Healthcare Group (OTCMKTS DSKX) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 19.40%
Institutional Ownership Percentage: 0.01%
DS Healthcare Group (OTCMKTS DSKX) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 7/17/2017 | Yasuhiro Fujiwara | CEO | Buy | 2,500,000 | $0.10 | $250,000.00 | 2,815,000 | |
| 6/25/2015 | Daniel Khesin | CEO | Buy | 3,000 | $3.25 | $9,750.00 | | |
| 6/23/2015 | Daniel Khesin | CEO | Buy | 2,225 | $4.51 | $10,034.75 | | |
| 6/18/2015 | Mark Edward Wolfson | Director | Sell | 27,650 | $4.28 | $118,342.00 | | |
| 6/15/2015 | Daniel Khesin | CEO | Buy | 3,500 | $3.71 | $12,985.00 | | |
| 5/21/2015 | Daniel Khesin | CEO | Buy | 1,000 | $2.07 | $2,070.00 | | |
| 11/17/2014 | Daniel Khesin | CEO | Buy | 1,000 | $0.80 | $800.00 | | |
| 11/7/2014 | Daniel Khesin | CEO | Buy | 1,000 | $0.85 | $850.00 | | |
| 9/10/2014 | Daniel Khesin | CEO | Buy | 1,000 | $1.09 | $1,090.00 | | |
| 9/10/2014 | Mark Edward Wolfson | Director | Buy | 2,389 | $1.09 | $2,604.01 | | |
| 8/22/2014 | Mark Edward Wolfson | Director | Buy | 2,650 | $1.10 | $2,915.00 | | |
| 7/17/2014 | Daniel Khesin | CEO | Buy | 1,000 | $1.40 | $1,400.00 | | |
| 7/15/2014 | Daniel Khesin | CEO | Buy | 1,000 | $1.43 | $1,430.00 | | |
| 1/17/2014 | Michael Strong | Major Shareholder | Sell | 12,465 | $2.50 | $31,162.50 | | |
(Data available from 1/1/2013 forward)
DS Healthcare Group (OTCMKTS DSKX) News Headlines
| Source: |
|
DS Healthcare Group (OTCMKTS:DSKX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
DS Healthcare Group (OTCMKTS:DSKX) Income Statement, Balance Sheet and Cash Flow Statement
DS Healthcare Group (OTCMKTS DSKX) Stock Chart for Sunday, May, 20, 2018
Loading chart…
